On-person adaptive evolution of Staphylococcus aureus during treatment for atopic dermatitis
Publication information:
Felix Key, Veda Khadka, Carolina Romo-González, Kimbria Blake, Liwen Deng, Tucker Lynn, Jean Lee, Isaac Chiu, Maria García-Romero, and Tami Lieberman. 2023. “On-Person Adaptive Evolution of Staphylococcus Aureus During Treatment for Atopic Dermatitis”. Cell Host Microbe, 31, 4, Pp. 593-603.e7. doi:10.1016/j.chom.2023.03.009
Abstract
The opportunistic pathogen Staphylococcus aureus frequently colonizes the inflamed skin of people with atopic dermatitis (AD) and worsens disease severity by promoting skin damage. Here, we show, by longitudinally tracking 23 children treated for AD, that S. aureus adapts via de novo mutations during colonization. Each patient's S. aureus population is dominated by a single lineage, with infrequent invasion by distant lineages. Mutations emerge within each lineage at rates similar to those of S. aureus in other contexts. Some variants spread across the body within months, with signatures of adaptive evolution. Most strikingly, mutations in capsule synthesis gene capD underwent parallel evolution in one patient and across-body sweeps in two patients. We confirm that capD negativity is more common in AD than in other contexts, via reanalysis of S. aureus genomes from 276 people. Together, these findings highlight the importance of the mutation level when dissecting the role of microbes in complex disease.